IDx-DR

Businesspeople looking at financial charts.
Digital Diagnostics scores $75M to advance AI-backed diagnostic tech
By Emily Olsen | 12:27 pm | August 23, 2022
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
Study results support FDA approval of diagnostic algorithm, but experts remain wary
By Dave Muoio | 04:17 pm | August 28, 2018
FDA permits marketing of AI software that autonomously detects diabetic retinopathy
By Dave Muoio | 12:10 pm | April 12, 2018